Rationally designed Mycoplasma gallisepticum vaccine using a recombinant subunit approach
Jeremy M. Miller, Rosemary Grace Ozyck, Patrick L Pagano, Esmeralda F Hernandez, Megan E Davis, Anton Q Karam, Jessica B. Malek, Arlind B. Mara 等 11 位
University of Connecticut
阅读操作
确认中在文库中上传 PDF 后可生成中文音频讲解。
摘要与影响
Mycoplasma gallisepticum (MG) is an avian respiratory pathogen causing significant global economic losses to the poultry industries. Current live-attenuated and bacterin vaccines provide some measures of protective immunity but exhibit suboptimal efficacy, utility, or safety. To address these shortcomings, we utilized knowledge of MG biology and virulence to develop a subunit vaccine containing recombinantly produced primary adhesin GapA, cytadhesin-related molecule CrmA, and four early-phase-expressed variable lipoprotein hemagglutinins (VlhAs) (3.03, 3.06, 4.07, 5.05) of the virulent strain Rlow. The vaccine was tested in chickens using a subcutaneous dose of 50 µg per protein, a prime-boost schedule, and strain Rlow challenge in multiple studies to compare adjuvant formulations. While different adjuvants resulted in variable levels of protection, only CpG oligodeoxynucleotide (CpG ODN 2007) resulted in significant reductions of both MG recovery and tracheal pathology. These results demonstrate that a rationally designed and safe subunit vaccine is efficacious against MG disease.
逐年被引趋势
关键指标
同类平均 = 1
同领域 · 同年份 · 同类型
Google Scholar 与 OpenAlex 的被引统计范围不同,数值存在差异属正常。
AI 辅助阅读
依据:摘要
可就本文提问;依据不足时会说明。
学术脉络
学科主题
生物医学Microbial infections and disease research
Animal Virus Infections Studies · Bird parasitology and diseases
参考文献 65
此处列出前 3 条
引用本文 11
按被引量排序,此处列出前 3 条